Phase 2 safety trial targeting amyloid β production with a γ-secretase inhibitor in Alzheimer disease

Adam S. Fleisher, Rema Raman, Eric R. Siemers, Lida Becerra, Christopher M. Clark, Robert A. Dean, Martin R. Farlow, James E. Galvin, Elaine R. Peskind, Joseph F. Quinn, Abdullah Sherzai, B. Brooke Sowell, Paul S. Aisen, Leon J. Thal

Research output: Contribution to journalArticlepeer-review

300 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 2 safety trial targeting amyloid β production with a γ-secretase inhibitor in Alzheimer disease'. Together they form a unique fingerprint.

Medicine & Life Sciences

Arts & Humanities